ACO Name and Location

Loudoun Medical Group ACO LLC
Previous Names: N/A
224D Cornwall St NW
Ste 403
Leesburg, VA 20176

ACO Primary Contact

Primary Contact Name	Mary Beth Tamasy, CEO
Primary Contact Phone Number	703-737-6006
Primary Contact Email Address	mtamasy@lmgdoctors.com

---

Organizational Information

ACO Participants	ACO Participant in Joint Venture (Enter Y or N)
Loudoun Medical Group PC	N

ACO Governing Body:

Member			Member’s Voting Power*	Membership Type	ACO Participant**
Last Name	First Name	Title/Position
Crowley, MD	Anthony	Chairman	1.00	ACO Participant Representative	Loudoun Medical Group PC
Calihan, MD	Martha	Voting Member	1.00	ACO Participant Representative	Loudoun Medical Group PC
Kuo, MD	Michael	Voting Member	1.00	ACO Participant Representative	Loudoun Medical Group PC
Hetzel, MD	Robert	Voting Member	1.00	ACO Participant Representative	Loudoun Medical Group PC
Mellis, MD	Michael G.	Voting Member	1.00	ACO Participant Representative	Loudoun Medical Group PC
Beloy, MD	Amie	Voting Member	1.00	ACO Participant Representative	Loudoun Medical Group PC
Nekoba, MD	Jeffrey	Voting Member	1.00	ACO Participant Representative	Loudoun Medical Group PC
Thompson, MD	Jennifer B.	Voting Member	1.00	ACO Participant Representative	Loudoun Medical Group PC
Akhtar, MD	Nauman	Voting Member	1.00	ACO Participant Representative	Loudoun Medical Group PC
Tamasy	Mary Beth	Voting Member	1.00	ACO Participant Representative	Loudoun Medical Group PC
Kearns	Kathryn	Voting Member	1.00	Medicare Beneficiary Representative	Loudoun Medical Group PC

* Expressed as a percentage or number
** Legal Business Name/DBA, if Applicable

Key ACO Clinical and Administrative Leadership:

Mary Beth Tamasy	ACO Executive
Anthony Crowley	Medical Director
Clara Nussbaum	Compliance Officer
Clara Nussbaum	Quality Assurance/Improvement Officer

Associated Committees and Committee Leadership:

Quality Assurance and Improvement Committee – Anthony Crowley, MD, Chair
Finance Committee –  Robert Hetzel, MD, Chair
Communications Committee – Linda Coleman, MD, Chair

---

Types of ACO participants, or combinations of participants, that formed the ACO:

• ACO professionals in a group practice arrangement

---

Amount of Shared Savings/Losses:

• Third Agreement Period
  • Performance Year 2020, $0
• Second Agreement Period
  • Performance Year 2019, $0
  • Performance Year 2018, $0
  • Performance Year 2017, $1,272,644
• Second Agreement Period
  • Performance Year 2016, $0
  • Performance Year 2015, $0
  • Performance Year 2014, $0

Shared Savings Distribution:

• Third Agreement Period
  • Performance Year 2020
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A 
• Second Agreement Period
  • Performance Year 2019
    • Proportion invested in infrastructure: N/A 
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants N/A
  • Performance Year 2018
    • Proportion invested in infrastructure: N/A 
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A 
  • Performance Year 2017
    • Proportion invested in infrastructure: 30% 
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 40%
• First Agreement Period
  • Performance Year 2016
    • Proportion invested in infrastructure: N/A  
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A 
  • Performance Year 2015
    • Proportion invested in infrastructure: N/A 
    • Proportion invested in redesigned care processes/resources: N/A 
    • Proportion of distribution to ACO participants: N/A 
  • Performance Year 2014
    • Proportion invested in infrastructure: N/A 
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A

 

---

Quality Performance Results

2020 Quality Performance Results:

You may need to scroll horizontally to view all of the data.

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

2020 Quality Performance Results:

ACO #	Measure Name	Rate	ACO Mean
ACO-43	Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))	0.94	0.95
ACO-13	Falls: Screening for Future Fall Risk	77.60	84.97
ACO-14	Preventive Care and Screening: Influenza Immunization	66.80	76.03
ACO-17	Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention	28.57	81.67
ACO-18	Preventive Care and Screening: Screening for Depression and Follow-up Plan	31.34	71.46
ACO-19	Colorectal Cancer Screening	65.56	72.59
ACO-20	Breast Cancer Screening	57.58	74.05
ACO-42	Statin Therapy for the Prevention and Treatment of Cardiovascular Disease	81.50	83.37
ACO-27	Diabetes Mellitus: Hemoglobin A1c Poor Control	12.25	14.70
ACO-28	Hypertension (HTN): Controlling High Blood Pressure	69.20	72.87

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

Payment Rule Waivers

• Waiver for Payment for Telehealth Services:
  • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR §425.612(f) and 42 CFR §425.613.